Elsevier

Journal of Ethnopharmacology

Volume 103, Issue 3, 20 February 2006, Pages 338-344
Journal of Ethnopharmacology

Anti-inflammatory activity of four Bolivian Baccharis species (Compositae)

https://doi.org/10.1016/j.jep.2005.08.024Get rights and content

Abstract

Hexanic, dichloromethanic, ethanolic and aqueous extracts from Baccharis obtusifolia HBK, Baccharis latifolia (R. et P.) Pers., Baccharis pentlandii D.C. and Baccharis subulata Wedd., plants used in the traditional medicine of South America have been studied for their in vitro anti-inflammatory activity in cellular systems. Calcium ionophore A23187-stimulated mouse peritoneal macrophages were validated as a source of cyclooxygenase-1 (COX-1) (prostaglandin E2, PGE2) and 5-lipoxygenase (5-LOX) (leukotriene C4, LTC4), and mouse peritoneal macrophages stimulated with Escherichia coli lipopolysaccharide (LPS) were used for testing cyclooxygenase-2 (COX-2) (PGE2), nitric oxide (NO) and tumour necrosis factor-α (TNF-α) activity. Most of the extracts tested were active in all assays.

Introduction

Medicinal plants are an important element of indigenous medical systems in South American countries and elsewhere and these resources are usually regarded as part of a culture's traditional knowledge. For many years, Europe has profited from exchange with other continents, and many of the pure natural products and some of the phytotherapeutic preparations used today are derived from plants used in indigenous cultures. The role of the ethnobotanist in the search for new drugs was of continuous importance until the second half of the 20th century, when other approaches became more “fashionable”. However, in recent years, the use of such information in medicinal plant research for drug development has again received considerable interest in the media and in some segments of the scientific community (Heinrich, 2000).

The large American genus Baccharis (Compositae) comprises about 400 species. Of them, 20% are locally used for medicinal purposes or, to a lesser extent, as food or as raw material for different local industries. Several species of this genus have been investigated chemically or pharmacologically for their anti-inflammatory properties (Gene et al., 1992, Gene et al., 1996, De las Heras et al., 1998, Gianello et al., 1999, Perez-García et al., 2001, Cifuente et al., 2001, Parejo et al., 2003, Tapia et al., 2004). In a search for new substances with anti-inflammatory activity, organic and aqueous extracts of Baccharis obtusifolia HBK, Baccharis latifolia (R. et P.) Pers., Baccharis pentlandii D.C. and Baccharis subulata Wedd. were tested in vitro. These plants are used in the form of decoctions in the traditional medicine of South America for the treatment of rheumatism, liver diseases, wounds and ulcers. In the course of our biological search for anti-inflammatory agents, the present paper was undertaken in order to investigate the effects of these extracts on some macrophage functions involved in the inflammatory process. These extracts have been tested in two experimental systems: ionophore-stimulated mouse peritoneal macrophages serve as source of cyclooxygenase-1 (COX-1) and 5-lipoxygenase (5-LOX), and mouse peritoneal macrophages stimulated with Escherichia coli lipopolysaccharide (LPS) are the means of testing for cyclooxygenase-2 (COX-2), nitric oxide (NO) and tumour necrosis factor-α (TNF-α) activity.

Section snippets

Plant material

The plants were authenticated by the Herbarium of the Faculty of Pharmacy, Mayor University of San Andres, La Paz, Bolivia. A voucher specimen of each plant has been deposited at this herbarium. All plants were collected at the flowering stage. Data on plant material are summarised in Table 1.

Preparation of extracts

For each plant material, four extracts of different polarity were prepared as follows:

Results

Hexanic and dichloromethanic extracts were generally more toxic to mouse peritoneal macrophages than ethanolic and aqueous extracts. None of the ethanolic and aqueous extracts tested showed a cytotoxic effect on cells up to a concentration of 200 μg/ml. The dichloromethanic extract of Baccharis obtusifolia and the hexanic and dichloromethanic extracts of Baccharis latifolia were cytotoxic up to a concentration of 50 μg/ml, while the dichloromethanic extracts of Baccharis pentlandii and Baccharis

Discussion

During the past 15 years, the understanding of the mechanisms and molecules of inflammation have expanded dramatically. The discovery of entirely new classes of protein and lipid mediators of inflammation have clearly changed the perception of the pathogenesis of inflammation and have begun to take new approaches to the development of drugs for the therapy of inflammatory diseases (Cronstein and Weissmann, 1995). Macrophages play an important tissue-damaging role in a number of inflammatory

Acknowledgements

This work was supported by Programa de Cooperación Científica con Iberoamérica (PR 77/00-8992) from Ministerio de Educación, Cultura y Deporte. This work was also supported by Proyecto de Investigacion UCM (052/PR13282). The technical assistance of Ms. P. Brooke-Turner is gratefully acknowledged.

References (22)

  • B.N. Cronstein et al.

    Targets for antiinflammatory drugs

    Annual Review of Pharmacology and Toxicology

    (1995)
  • Cited by (39)

    • Anti-inflammatory activity of Baccharis notosergila against lipopolysaccharide (LPS)-induced inflammation and identification of active fractions and their chemical constituents

      2023, European Journal of Integrative Medicine
      Citation Excerpt :

      Notably, the NO levels produced by LPS-stimulated monocytes treated with the extract were similar to that of the unstimulated control cells. Similar to our findings, other Baccharis species also decrease LPS-stimulated NO production [40]. Further studies are needed to determine the exact extract mechanism of action on NO production.

    • Seasonal changes in phenolic compounds and in the biological activities of Baccharis dentata (Vell.) G.M. Barroso

      2013, Industrial Crops and Products
      Citation Excerpt :

      Several species of this genus have been investigated chemically or pharmacologically for their medicinal use and for potential new drugs (Abad and Bermejo, 2007; Parejo et al., 2003). Cytotoxic and anti-inflammatory properties are commonly reported for extracts obtained from Baccharis (Abad et al., 2006; Ferronatto et al., 2007; Rosas-Burgo et al., 2009). Different molecules with anti-tumor action have been described from leaves of Baccharis dracunculifolia (Fukuda et al., 2006).

    • Evaluation of the key odorants of Baccharis anomala DC essential oil: New applications for known products

      2013, Industrial Crops and Products
      Citation Excerpt :

      In this context, several species of the genus Baccharis spp. have been object of research because of their growing importance as a source of new active ingredients with different applications (Frizzo et al., 2001). Baccharis species have also been used in traditional medicine to treat wounds, ulcers, fever, gastrointestinal diseases such as spasmolytic, diuretic, analgesic, in diabetes, anti-inflammatory (Herz et al., 1977; Loayza et al., 1995; Abad et al., 2006; Budel and Duarte, 2008), in the treatment of bacterial and fungal infections as an antiseptic and healing agent for external use (Abad and Bermejo, 2007), antimicrobial (Oliva et al., 2007; Simionatto et al., 2008) and antioxidant activity (Oliveira et al., 2003). Moreover, some species have also applications in perfumery and cosmetics industry (Queiroga et al., 1990) and have pharmacological properties (Verdi et al., 2005).

    • In vitro and in vivo toxicological evaluation of extract and fractions from Baccharis trimera with anti-inflammatory activity

      2011, Journal of Ethnopharmacology
      Citation Excerpt :

      The popular use of Baccharis trimera consists of drinking 50–200 ml/day of an aqueous infusion (4–5 g) of the dried herb (Coimbra, 1942). Several species of the Baccharis genus as Baccharis articulate and Baccharis crispa (Gené et al., 1992), Baccharis trinervis (De las Heras et al., 1998), Baccharis calliprinos and Baccharis rethinoides (Gianello et al., 1999), Baccharis grisebachii, Baccharis incarum and Baccharis latifolia (Perez-García et al., 2001), Baccharis medullosa and B. rufescens (Cifuente et al., 2001), Baccharis pentlandii (Parejo et al., 2003), Baccharis grisebachii (Tapia et al., 2004), Baccharis genistelloides (Coelho et al., 2004), Baccharis obtusifolia, Baccharis latifolia, Baccharis pentlandii and Baccharis subulata (Abad et al., 2006), as well as Baccharis trimera (Gené et al., 1992, 1996) have been investigated for their chemical composition and anti-inflammatory properties. On the other hand, toxic effects to animals have been reported for Baccharis halimifolia, Baccharis cordifolia DC.

    • Chemistry and biological activities of phenolic compounds from baccharis genus

      2022, Baccharis: From Evolutionary and Ecological Aspects to Social Uses and Medicinal Applications
    View all citing articles on Scopus
    View full text